Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, June 09, 2009

Does repeat usage of bevacizumab in patients with progressive recurrent ovarian cancer offer a survival advantage? -- Richardson et al. 27 (15): e16510 -- ASCO Meeting Abstracts


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.